{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:03:14Z","timestamp":1780621394779,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Research and Innovative Team Project for Scientific Breakthroughs at Shanxi Bethune Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01483-8","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:24:01Z","timestamp":1776932641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fludarabine disrupts the STAT1\/AhR interaction to attenuate type 1 diabetes by inducing tolerogenic dendritic cells along with targeting effector T cells"],"prefix":"10.1186","volume":"32","author":[{"given":"Shan-Jie","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Chao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Ni","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam S.","family":"Al-Motawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Albagha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Tian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"6","key":"1483_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ni794","volume":"3","author":"M Afkarian","year":"2002","unstructured":"Afkarian M, Sedy JR, Yang J, et al. T-bet is a STAT1-induced regulator of IL-12R expression in na\u00efve CD4+ T cells[J]. Nat Immunol. 2002;3(6):549\u201357.","journal-title":"Nat Immunol"},{"issue":"8","key":"1483_CR2","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.2337\/db13-0106","volume":"62","author":"AD Barlow","year":"2013","unstructured":"Barlow AD, Nicholson ML, Herbert TP. Evidence for rapamycin toxicity in pancreatic \u03b2-cells and a review of the underlying molecular mechanisms. Diabetes. 2013;62(8):2674\u201382.","journal-title":"Diabetes"},{"issue":"15","key":"1483_CR3","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1056\/NEJMc2022226","volume":"383","author":"NS Chaimowitz","year":"2020","unstructured":"Chaimowitz NS, Ebenezer SJ, Hanson IC, et al. STAT1 gain of function, type 1 diabetes, and reversal with JAK Inhibition[J]. N Engl J Med. 2020;383(15):1494\u20136.","journal-title":"N Engl J Med"},{"key":"1483_CR4","doi-asserted-by":"crossref","unstructured":"Chatenoud L, Warncke K, Ziegler AG. Clinical immunologic interventions for the treatment of type 1 diabetes[J]. Cold Spring Harbor perspectives in medicine. 2012;2(8):a007716.","DOI":"10.1101\/cshperspect.a007716"},{"issue":"5","key":"1483_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrd.2015.6","volume":"15","author":"M Conrad","year":"2016","unstructured":"Conrad M, Angeli JP, Vandenabeele P, et al. Regulated necrosis: disease relevance and therapeutic opportunities[J]. Nat Rev Drug Discovery. 2016;15(5):348\u201366.","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"1483_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nm.3044","volume":"19","author":"RJ Creusot","year":"2013","unstructured":"Creusot RJ. Initiating type I diabetes: new suspects in the lineup. Nat Med. 2013;19(1):18\u201320.","journal-title":"Nat Med"},{"issue":"1","key":"1483_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2337\/db13-0886","volume":"63","author":"RJ Creusot","year":"2014","unstructured":"Creusot RJ, Giannoukakis N, Trucco M, et al. It\u2019s time to bring dendritic cell therapy to type 1 diabetes[J]. Diabetes. 2014;63(1):20\u201330.","journal-title":"Diabetes"},{"issue":"8","key":"1483_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/db17-1564","volume":"67","author":"RJ Creusot","year":"2018","unstructured":"Creusot RJ, Postigo-Fernandez J, Teteloshvili N. Altered function of antigen-presenting cells in type 1 diabetes: a challenge for antigen-specific immunotherapy? Diabetes. 2018;67(8):1481\u201394.","journal-title":"Diabetes"},{"key":"1483_CR9","doi-asserted-by":"crossref","unstructured":"Dai C, Walker JT, Shostak A, et al. Tacrolimus- and sirolimus-induced human \u03b2 cell dysfunction is reversible and preventable[J]. JCI insight. 2020;5(1):e130770.","DOI":"10.1172\/jci.insight.130770"},{"issue":"2","key":"1483_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/db18-0627","volume":"68","author":"M Fabbri","year":"2019","unstructured":"Fabbri M, Frixou M, Degano M, et al. Type 1 Diabetes in STAT protein family mutations: regulating the Th17\/Treg equilibrium and beyond[J]. Diabetes. 2019;68(2):258\u201365.","journal-title":"Diabetes"},{"issue":"13","key":"1483_CR11","doi-asserted-by":"publisher","first-page":"e2219956120","DOI":"10.1073\/pnas.2219956120","volume":"120","author":"ST Ferris","year":"2023","unstructured":"Ferris ST, Liu T, Chen J, et al. WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis[J]. Proc Natl Acad Sci USA. 2023;120(13):e2219956120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1483_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/7445","volume":"5","author":"DA Frank","year":"1999","unstructured":"Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med. 1999;5(4):444\u20137.","journal-title":"Nat Med"},{"issue":"5","key":"1483_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00281-014-0438-4","volume":"36","author":"P In\u2019t Veld","year":"2014","unstructured":"In\u2019t Veld P. Insulitis in human type 1 diabetes: a comparison between patients and animal models[J]. Semin Immunopathol. 2014;36(5):569\u201379.","journal-title":"Semin Immunopathol"},{"key":"1483_CR14","doi-asserted-by":"publisher","first-page":"858462","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana N, Ta KT, DelGiorno KE. The Role of Cystine\/Glutamate Antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front Oncol. 2022;12:858462.","journal-title":"Front Oncol"},{"issue":"10","key":"1483_CR15","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2337\/db06-1372","volume":"56","author":"S Kim","year":"2007","unstructured":"Kim S, Kim HS, Chung KW, et al. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice[J]. Diabetes. 2007;56(10):2561\u20138.","journal-title":"Diabetes"},{"issue":"703","key":"1483_CR16","doi-asserted-by":"publisher","first-page":"eade7028","DOI":"10.1126\/scitranslmed.ade7028","volume":"15","author":"AD Largent","year":"2023","unstructured":"Largent AD, Lambert K, Chiang K, et al. Dysregulated IFN-\u03b3 signals promote autoimmunity in STAT1 gain-of-function syndrome[J]. Sci Transl Med. 2023;15(703):eade7028.","journal-title":"Sci Transl Med"},{"issue":"9","key":"1483_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41419-021-04122-8","volume":"12","author":"JY Li","year":"2021","unstructured":"Li JY, Ren C, Wang LX, et al. Sestrin2 protects dendrite cells against ferroptosis induced by sepsis[J]. Cell Death Dis. 2021;12(9):834.","journal-title":"Cell Death Dis"},{"issue":"10","key":"1483_CR18","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.cmet.2024.08.009","volume":"36","author":"JH Luo","year":"2024","unstructured":"Luo JH, Wang FX, Zhao JW, et al. PDIA3 defines a novel subset of adipose macrophages to exacerbate the development of obesity and metabolic disorders[J]. Cell Metab. 2024;36(10):2262-80.e5.","journal-title":"Cell Metab"},{"issue":"1","key":"1483_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Chen C, Zhao C, et al. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer[J]. Signal Transduct Target Ther. 2024;9(1):64.","journal-title":"Signal Transduct Target Ther"},{"key":"1483_CR20","doi-asserted-by":"publisher","first-page":"857143","DOI":"10.1155\/2014\/857143","volume":"2014","author":"J Mbongue","year":"2014","unstructured":"Mbongue J, Nicholas D, Firek A, et al. The role of dendritic cells in tissue-specific autoimmunity[J]. J Immunol Res. 2014;2014:857143.","journal-title":"J Immunol Res"},{"issue":"5","key":"1483_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","volume":"40","author":"A Mildner","year":"2014","unstructured":"Mildner A, Jung S. Development and function of dendritic cell subsets. Immunity. 2014;40(5):642\u201356.","journal-title":"Immunity"},{"issue":"9","key":"1483_CR22","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.2337\/db08-0138","volume":"57","author":"P Monti","year":"2008","unstructured":"Monti P, Scirpoli M, Maffi P, et al. Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells[J]. Diabetes. 2008;57(9):2341\u20137.","journal-title":"Diabetes"},{"issue":"1","key":"1483_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","volume":"42","author":"O Morante-Palacios","year":"2021","unstructured":"Morante-Palacios O, Fondelli F, Ballestar E, et al. Tolerogenic dendritic cells in autoimmunity and inflammatory diseases[J]. Trends Immunol. 2021;42(1):59\u201375.","journal-title":"Trends Immunol"},{"key":"1483_CR24","doi-asserted-by":"crossref","unstructured":"Powers AC. Type 1 diabetes mellitus: much progress, many opportunities [J].\u00a0J Clin Invest. 2021;131(8):e142242.","DOI":"10.1172\/JCI142242"},{"issue":"25","key":"1483_CR25","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1161\/CIRCULATIONAHA.110.966408","volume":"123","author":"X Rao","year":"2011","unstructured":"Rao X, Zhong J, Zhang S, et al. Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury[J]. Circulation. 2011;123(25):2964\u201374.","journal-title":"Circulation"},{"key":"1483_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-immunol-031210-101345","volume":"29","author":"B Reizis","year":"2011","unstructured":"Reizis B, Bunin A, Ghosh HS, et al. Plasmacytoid dendritic cells: recent progress and open questions[J]. Annu Rev Immunol. 2011;29:163\u201383.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"1483_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/08830185.2023.2274576","volume":"43","author":"S Sohrabi","year":"2024","unstructured":"Sohrabi S, Masoumi J, Naseri B, et al. STATs signaling pathways in dendritic cells: as potential therapeutic targets?[J]. Int Rev Immunol. 2024;43(3):138\u201359.","journal-title":"Int Rev Immunol"},{"key":"1483_CR28","first-page":"e075681","volume":"384","author":"S Subramanian","year":"2024","unstructured":"Subramanian S, Khan F, Hirsch IB. New advances in type 1 diabetes. BMJ (Clin Res Ed). 2024;384:e075681.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"2","key":"1483_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas NJ, Jones SE, Weedon MN, et al. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK biobank. Lancet Diabetes Endocrinol. 2018;6(2):122\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1483_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00281-016-0583-z","volume":"39","author":"A Waisman","year":"2017","unstructured":"Waisman A, Lukas D, Clausen BE, et al. Dendritic cells as gatekeepers of tolerance[J]. Semin Immunopathol. 2017;39(2):153\u201363.","journal-title":"Semin Immunopathol."},{"issue":"12","key":"1483_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2130-z","volume":"10","author":"F Wang","year":"2019","unstructured":"Wang F, Sun F, Luo J, et al. Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization. Cell Death Dis. 2019;10(12):892.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1483_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc()[J]. Cell Death Differ. 2020;27(2):662\u201375.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1483_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","volume":"31","author":"JT Warshauer","year":"2020","unstructured":"Warshauer JT, Bluestone JA, Anderson MS. New frontiers in the treatment of type 1 diabetes. Cell Metab. 2020;31(1):46\u201361.","journal-title":"Cell Metab"},{"issue":"2","key":"1483_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.08570814","volume":"11","author":"AC Wiseman","year":"2016","unstructured":"Wiseman AC. Immunosuppressive medications. Clin J Am Soc Nephrol. 2016;11(2):332\u201343.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1483_CR35","doi-asserted-by":"publisher","first-page":"e158352","DOI":"10.1172\/JCI158352","volume":"133","author":"J Xiao","year":"2023","unstructured":"Xiao J, Sun F, Wang YN, et al. UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer[J]. J Clin Invest. 2023;133(4):e158352.","journal-title":"J Clin Invest"},{"key":"1483_CR36","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3389\/fimmu.2020.01510","volume":"11","author":"T Yue","year":"2020","unstructured":"Yue T, Sun F, Yang C, et al. The AHR signaling attenuates autoimmune responses during the development of Type 1 diabetes. Front Immunol. 2020;11:1510.","journal-title":"Front Immunol"},{"issue":"1","key":"1483_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41418-021-00852-6","volume":"29","author":"T Yue","year":"2022","unstructured":"Yue T, Sun F, Wang F, et al. MBD2 acts as a repressor to maintain the homeostasis of the Th1 program in type 1 diabetes by regulating the STAT1-IFN-\u03b3 axis[J]. Cell Death Differ. 2022;29(1):218\u201329.","journal-title":"Cell Death Differ"},{"issue":"6","key":"1483_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The Metabolic Underpinnings of Ferroptosis. Cell Metab. 2020;32(6):920\u201337.","journal-title":"Cell Metab"},{"issue":"1","key":"1483_CR39","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1038\/s41467-024-53264-8","volume":"15","author":"T Zhong","year":"2024","unstructured":"Zhong T, Li X, Lei K, et al. TGF-\u03b2-mediated crosstalk between TIGIT(+) Tregs and CD226(+)CD8(+) T cells in the progression and remission of type 1 diabetes. Nat Commun. 2024;15(1):8894.","journal-title":"Nat Commun"},{"issue":"3","key":"1483_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.immuni.2018.03.008","volume":"48","author":"GM Zu Horste","year":"2018","unstructured":"Zu Horste GM, Przybylski D, Schramm MA, et al. Fas Promotes T Helper 17 cell differentiation and inhibits T Helper 1 cell development by binding and sequestering transcription Factor STAT1[J]. Immunity. 2018;48(3):556-69.e7.","journal-title":"Immunity"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01483-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:35:20Z","timestamp":1780619720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01483-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01483-8","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols for animal studies were approved by the Tongji Hospital Animal Care and Use Committee (TJH-202207020) in accordance with the National Institutes of Health guidelines. All studies in humans were conducted in accordance with the NIH guidelines and consent form was obtained from each study subject, and the study was approved by the Tongji Hospital Human Assurance Committee (YXLL-2023\u2013196).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}